 | • レポートコード：QYR2104Z4559 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、134ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、製薬CMOサービスのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（有効成分（API）、完成用量製剤（FDF）、パッケージング）、用途別市場規模（製薬産業、バイオテクノロジー産業）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・製薬CMOサービスの市場動向 ・企業の競争状況、市場シェア ・製薬CMOサービスの種類別市場規模（有効成分（API）、完成用量製剤（FDF）、パッケージング） ・製薬CMOサービスの用途別市場規模（製薬産業、バイオテクノロジー産業） ・製薬CMOサービスの北米市場規模2016-2027（アメリカ、カナダ） ・製薬CMOサービスのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・製薬CMOサービスのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・製薬CMOサービスの中南米市場規模2016-2027（メキシコ、ブラジル） ・製薬CMOサービスの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Lonza、Boehringer Ingelheim、FUJIFILM Diosynth Biotechnologies、AGC Chemicals、AbbVie、Pfizer、Evonik Health Care、Delpharm、Recipharm、Teva API、Catalent、Esteve Quimica、Fareva、Patheon、Piramal、Hisun Pharmaceuticals） ・結論 |
Market Analysis and Insights: Global Pharmaceutical CMO Services Market
The global Pharmaceutical CMO Services market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pharmaceutical CMO Services market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pharmaceutical CMO Services market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pharmaceutical CMO Services market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pharmaceutical CMO Services market.
Global Pharmaceutical CMO Services Scope and Market Size
Pharmaceutical CMO Services market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pharmaceutical CMO Services market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Active Pharmaceutical Ingredients (APIs)
Finished Dose Formulations (FDFs)
Packaging
Segment by Application
Pharmaceutical Industry
Biotechnology Industry
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Lonza
Boehringer Ingelheim
FUJIFILM Diosynth Biotechnologies
AGC Chemicals
AbbVie
Pfizer
Evonik Health Care
Delpharm
Recipharm
Teva API
Catalent
Esteve Quimica
Fareva
Patheon
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical CMO Services Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Active Pharmaceutical Ingredients (APIs)
1.2.3 Finished Dose Formulations (FDFs)
1.2.4 Packaging
1.3 Market by Application
1.3.1 Global Pharmaceutical CMO Services Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Pharmaceutical Industry
1.3.3 Biotechnology Industry
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical CMO Services Market Perspective (2016-2027)
2.2 Pharmaceutical CMO Services Growth Trends by Regions
2.2.1 Pharmaceutical CMO Services Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pharmaceutical CMO Services Historic Market Share by Regions (2016-2021)
2.2.3 Pharmaceutical CMO Services Forecasted Market Size by Regions (2022-2027)
2.3 Pharmaceutical CMO Services Industry Dynamic
2.3.1 Pharmaceutical CMO Services Market Trends
2.3.2 Pharmaceutical CMO Services Market Drivers
2.3.3 Pharmaceutical CMO Services Market Challenges
2.3.4 Pharmaceutical CMO Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical CMO Services Players by Revenue
3.1.1 Global Top Pharmaceutical CMO Services Players by Revenue (2016-2021)
3.1.2 Global Pharmaceutical CMO Services Revenue Market Share by Players (2016-2021)
3.2 Global Pharmaceutical CMO Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pharmaceutical CMO Services Revenue
3.4 Global Pharmaceutical CMO Services Market Concentration Ratio
3.4.1 Global Pharmaceutical CMO Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical CMO Services Revenue in 2020
3.5 Pharmaceutical CMO Services Key Players Head office and Area Served
3.6 Key Players Pharmaceutical CMO Services Product Solution and Service
3.7 Date of Enter into Pharmaceutical CMO Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical CMO Services Breakdown Data by Type
4.1 Global Pharmaceutical CMO Services Historic Market Size by Type (2016-2021)
4.2 Global Pharmaceutical CMO Services Forecasted Market Size by Type (2022-2027)
5 Pharmaceutical CMO Services Breakdown Data by Application
5.1 Global Pharmaceutical CMO Services Historic Market Size by Application (2016-2021)
5.2 Global Pharmaceutical CMO Services Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Pharmaceutical CMO Services Market Size (2016-2027)
6.2 North America Pharmaceutical CMO Services Market Size by Type
6.2.1 North America Pharmaceutical CMO Services Market Size by Type (2016-2021)
6.2.2 North America Pharmaceutical CMO Services Market Size by Type (2022-2027)
6.2.3 North America Pharmaceutical CMO Services Market Size by Type (2016-2027)
6.3 North America Pharmaceutical CMO Services Market Size by Application
6.3.1 North America Pharmaceutical CMO Services Market Size by Application (2016-2021)
6.3.2 North America Pharmaceutical CMO Services Market Size by Application (2022-2027)
6.3.3 North America Pharmaceutical CMO Services Market Size by Application (2016-2027)
6.4 North America Pharmaceutical CMO Services Market Size by Country
6.4.1 North America Pharmaceutical CMO Services Market Size by Country (2016-2021)
6.4.2 North America Pharmaceutical CMO Services Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Pharmaceutical CMO Services Market Size (2016-2027)
7.2 Europe Pharmaceutical CMO Services Market Size by Type
7.2.1 Europe Pharmaceutical CMO Services Market Size by Type (2016-2021)
7.2.2 Europe Pharmaceutical CMO Services Market Size by Type (2022-2027)
7.2.3 Europe Pharmaceutical CMO Services Market Size by Type (2016-2027)
7.3 Europe Pharmaceutical CMO Services Market Size by Application
7.3.1 Europe Pharmaceutical CMO Services Market Size by Application (2016-2021)
7.3.2 Europe Pharmaceutical CMO Services Market Size by Application (2022-2027)
7.3.3 Europe Pharmaceutical CMO Services Market Size by Application (2016-2027)
7.4 Europe Pharmaceutical CMO Services Market Size by Country
7.4.1 Europe Pharmaceutical CMO Services Market Size by Country (2016-2021)
7.4.2 Europe Pharmaceutical CMO Services Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical CMO Services Market Size (2016-2027)
8.2 Asia-Pacific Pharmaceutical CMO Services Market Size by Type
8.2.1 Asia-Pacific Pharmaceutical CMO Services Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pharmaceutical CMO Services Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pharmaceutical CMO Services Market Size by Type (2016-2027)
8.3 Asia-Pacific Pharmaceutical CMO Services Market Size by Application
8.3.1 Asia-Pacific Pharmaceutical CMO Services Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pharmaceutical CMO Services Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pharmaceutical CMO Services Market Size by Application (2016-2027)
8.4 Asia-Pacific Pharmaceutical CMO Services Market Size by Region
8.4.1 Asia-Pacific Pharmaceutical CMO Services Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pharmaceutical CMO Services Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Pharmaceutical CMO Services Market Size (2016-2027)
9.2 Latin America Pharmaceutical CMO Services Market Size by Type
9.2.1 Latin America Pharmaceutical CMO Services Market Size by Type (2016-2021)
9.2.2 Latin America Pharmaceutical CMO Services Market Size by Type (2022-2027)
9.2.3 Latin America Pharmaceutical CMO Services Market Size by Type (2016-2027)
9.3 Latin America Pharmaceutical CMO Services Market Size by Application
9.3.1 Latin America Pharmaceutical CMO Services Market Size by Application (2016-2021)
9.3.2 Latin America Pharmaceutical CMO Services Market Size by Application (2022-2027)
9.3.3 Latin America Pharmaceutical CMO Services Market Size by Application (2016-2027)
9.4 Latin America Pharmaceutical CMO Services Market Size by Country
9.4.1 Latin America Pharmaceutical CMO Services Market Size by Country (2016-2021)
9.4.2 Latin America Pharmaceutical CMO Services Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical CMO Services Market Size (2016-2027)
10.2 Middle East & Africa Pharmaceutical CMO Services Market Size by Type
10.2.1 Middle East & Africa Pharmaceutical CMO Services Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pharmaceutical CMO Services Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pharmaceutical CMO Services Market Size by Type (2016-2027)
10.3 Middle East & Africa Pharmaceutical CMO Services Market Size by Application
10.3.1 Middle East & Africa Pharmaceutical CMO Services Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pharmaceutical CMO Services Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pharmaceutical CMO Services Market Size by Application (2016-2027)
10.4 Middle East & Africa Pharmaceutical CMO Services Market Size by Country
10.4.1 Middle East & Africa Pharmaceutical CMO Services Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pharmaceutical CMO Services Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Details
11.1.2 Lonza Business Overview
11.1.3 Lonza Pharmaceutical CMO Services Introduction
11.1.4 Lonza Revenue in Pharmaceutical CMO Services Business (2016-2021)
11.1.5 Lonza Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Details
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Pharmaceutical CMO Services Introduction
11.2.4 Boehringer Ingelheim Revenue in Pharmaceutical CMO Services Business (2016-2021)
11.2.5 Boehringer Ingelheim Recent Development
11.3 FUJIFILM Diosynth Biotechnologies
11.3.1 FUJIFILM Diosynth Biotechnologies Company Details
11.3.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.3.3 FUJIFILM Diosynth Biotechnologies Pharmaceutical CMO Services Introduction
11.3.4 FUJIFILM Diosynth Biotechnologies Revenue in Pharmaceutical CMO Services Business (2016-2021)
11.3.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.4 AGC Chemicals
11.4.1 AGC Chemicals Company Details
11.4.2 AGC Chemicals Business Overview
11.4.3 AGC Chemicals Pharmaceutical CMO Services Introduction
11.4.4 AGC Chemicals Revenue in Pharmaceutical CMO Services Business (2016-2021)
11.4.5 AGC Chemicals Recent Development
11.5 AbbVie
11.5.1 AbbVie Company Details
11.5.2 AbbVie Business Overview
11.5.3 AbbVie Pharmaceutical CMO Services Introduction
11.5.4 AbbVie Revenue in Pharmaceutical CMO Services Business (2016-2021)
11.5.5 AbbVie Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Pharmaceutical CMO Services Introduction
11.6.4 Pfizer Revenue in Pharmaceutical CMO Services Business (2016-2021)
11.6.5 Pfizer Recent Development
11.7 Evonik Health Care
11.7.1 Evonik Health Care Company Details
11.7.2 Evonik Health Care Business Overview
11.7.3 Evonik Health Care Pharmaceutical CMO Services Introduction
11.7.4 Evonik Health Care Revenue in Pharmaceutical CMO Services Business (2016-2021)
11.7.5 Evonik Health Care Recent Development
11.8 Delpharm
11.8.1 Delpharm Company Details
11.8.2 Delpharm Business Overview
11.8.3 Delpharm Pharmaceutical CMO Services Introduction
11.8.4 Delpharm Revenue in Pharmaceutical CMO Services Business (2016-2021)
11.8.5 Delpharm Recent Development
11.9 Recipharm
11.9.1 Recipharm Company Details
11.9.2 Recipharm Business Overview
11.9.3 Recipharm Pharmaceutical CMO Services Introduction
11.9.4 Recipharm Revenue in Pharmaceutical CMO Services Business (2016-2021)
11.9.5 Recipharm Recent Development
11.10 Teva API
11.10.1 Teva API Company Details
11.10.2 Teva API Business Overview
11.10.3 Teva API Pharmaceutical CMO Services Introduction
11.10.4 Teva API Revenue in Pharmaceutical CMO Services Business (2016-2021)
11.10.5 Teva API Recent Development
11.11 Catalent
11.11.1 Catalent Company Details
11.11.2 Catalent Business Overview
11.11.3 Catalent Pharmaceutical CMO Services Introduction
11.11.4 Catalent Revenue in Pharmaceutical CMO Services Business (2016-2021)
11.11.5 Catalent Recent Development
11.12 Esteve Quimica
11.12.1 Esteve Quimica Company Details
11.12.2 Esteve Quimica Business Overview
11.12.3 Esteve Quimica Pharmaceutical CMO Services Introduction
11.12.4 Esteve Quimica Revenue in Pharmaceutical CMO Services Business (2016-2021)
11.12.5 Esteve Quimica Recent Development
11.13 Fareva
11.13.1 Fareva Company Details
11.13.2 Fareva Business Overview
11.13.3 Fareva Pharmaceutical CMO Services Introduction
11.13.4 Fareva Revenue in Pharmaceutical CMO Services Business (2016-2021)
11.13.5 Fareva Recent Development
11.14 Patheon
11.14.1 Patheon Company Details
11.14.2 Patheon Business Overview
11.14.3 Patheon Pharmaceutical CMO Services Introduction
11.14.4 Patheon Revenue in Pharmaceutical CMO Services Business (2016-2021)
11.14.5 Patheon Recent Development
11.15 Piramal
11.15.1 Piramal Company Details
11.15.2 Piramal Business Overview
11.15.3 Piramal Pharmaceutical CMO Services Introduction
11.15.4 Piramal Revenue in Pharmaceutical CMO Services Business (2016-2021)
11.15.5 Piramal Recent Development
11.16 Hisun Pharmaceuticals
11.16.1 Hisun Pharmaceuticals Company Details
11.16.2 Hisun Pharmaceuticals Business Overview
11.16.3 Hisun Pharmaceuticals Pharmaceutical CMO Services Introduction
11.16.4 Hisun Pharmaceuticals Revenue in Pharmaceutical CMO Services Business (2016-2021)
11.16.5 Hisun Pharmaceuticals Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Pharmaceutical CMO Services Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Active Pharmaceutical Ingredients (APIs)
Table 3. Key Players of Finished Dose Formulations (FDFs)
Table 4. Key Players of Packaging
Table 5. Global Pharmaceutical CMO Services Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Pharmaceutical CMO Services Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Pharmaceutical CMO Services Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Pharmaceutical CMO Services Market Share by Regions (2016-2021)
Table 9. Global Pharmaceutical CMO Services Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Pharmaceutical CMO Services Market Share by Regions (2022-2027)
Table 11. Pharmaceutical CMO Services Market Trends
Table 12. Pharmaceutical CMO Services Market Drivers
Table 13. Pharmaceutical CMO Services Market Challenges
Table 14. Pharmaceutical CMO Services Market Restraints
Table 15. Global Pharmaceutical CMO Services Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Pharmaceutical CMO Services Market Share by Players (2016-2021)
Table 17. Global Top Pharmaceutical CMO Services Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutical CMO Services as of 2020)
Table 18. Ranking of Global Top Pharmaceutical CMO Services Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Pharmaceutical CMO Services Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Pharmaceutical CMO Services Product Solution and Service
Table 22. Date of Enter into Pharmaceutical CMO Services Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Pharmaceutical CMO Services Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Pharmaceutical CMO Services Revenue Market Share by Type (2016-2021)
Table 26. Global Pharmaceutical CMO Services Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Pharmaceutical CMO Services Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Pharmaceutical CMO Services Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Pharmaceutical CMO Services Revenue Market Share by Application (2016-2021)
Table 30. Global Pharmaceutical CMO Services Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Pharmaceutical CMO Services Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Pharmaceutical CMO Services Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Pharmaceutical CMO Services Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Pharmaceutical CMO Services Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Pharmaceutical CMO Services Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Pharmaceutical CMO Services Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Pharmaceutical CMO Services Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Pharmaceutical CMO Services Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Pharmaceutical CMO Services Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Pharmaceutical CMO Services Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Pharmaceutical CMO Services Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Pharmaceutical CMO Services Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Pharmaceutical CMO Services Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Pharmaceutical CMO Services Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Pharmaceutical CMO Services Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Pharmaceutical CMO Services Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Pharmaceutical CMO Services Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Pharmaceutical CMO Services Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Pharmaceutical CMO Services Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Pharmaceutical CMO Services Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Pharmaceutical CMO Services Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Pharmaceutical CMO Services Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Pharmaceutical CMO Services Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Pharmaceutical CMO Services Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Pharmaceutical CMO Services Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Pharmaceutical CMO Services Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Pharmaceutical CMO Services Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Pharmaceutical CMO Services Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Pharmaceutical CMO Services Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Pharmaceutical CMO Services Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Pharmaceutical CMO Services Market Size by Country (2022-2027) & (US$ Million)
Table 62. Lonza Company Details
Table 63. Lonza Business Overview
Table 64. Lonza Pharmaceutical CMO Services Product
Table 65. Lonza Revenue in Pharmaceutical CMO Services Business (2016-2021) & (US$ Million)
Table 66. Lonza Recent Development
Table 67. Boehringer Ingelheim Company Details
Table 68. Boehringer Ingelheim Business Overview
Table 69. Boehringer Ingelheim Pharmaceutical CMO Services Product
Table 70. Boehringer Ingelheim Revenue in Pharmaceutical CMO Services Business (2016-2021) & (US$ Million)
Table 71. Boehringer Ingelheim Recent Development
Table 72. FUJIFILM Diosynth Biotechnologies Company Details
Table 73. FUJIFILM Diosynth Biotechnologies Business Overview
Table 74. FUJIFILM Diosynth Biotechnologies Pharmaceutical CMO Services Product
Table 75. FUJIFILM Diosynth Biotechnologies Revenue in Pharmaceutical CMO Services Business (2016-2021) & (US$ Million)
Table 76. FUJIFILM Diosynth Biotechnologies Recent Development
Table 77. AGC Chemicals Company Details
Table 78. AGC Chemicals Business Overview
Table 79. AGC Chemicals Pharmaceutical CMO Services Product
Table 80. AGC Chemicals Revenue in Pharmaceutical CMO Services Business (2016-2021) & (US$ Million)
Table 81. AGC Chemicals Recent Development
Table 82. AbbVie Company Details
Table 83. AbbVie Business Overview
Table 84. AbbVie Pharmaceutical CMO Services Product
Table 85. AbbVie Revenue in Pharmaceutical CMO Services Business (2016-2021) & (US$ Million)
Table 86. AbbVie Recent Development
Table 87. Pfizer Company Details
Table 88. Pfizer Business Overview
Table 89. Pfizer Pharmaceutical CMO Services Product
Table 90. Pfizer Revenue in Pharmaceutical CMO Services Business (2016-2021) & (US$ Million)
Table 91. Pfizer Recent Development
Table 92. Evonik Health Care Company Details
Table 93. Evonik Health Care Business Overview
Table 94. Evonik Health Care Pharmaceutical CMO Services Product
Table 95. Evonik Health Care Revenue in Pharmaceutical CMO Services Business (2016-2021) & (US$ Million)
Table 96. Evonik Health Care Recent Development
Table 97. Delpharm Company Details
Table 98. Delpharm Business Overview
Table 99. Delpharm Revenue in Pharmaceutical CMO Services Business (2016-2021) & (US$ Million)
Table 100. Delpharm Recent Development
Table 101. Recipharm Company Details
Table 102. Recipharm Business Overview
Table 103. Recipharm Pharmaceutical CMO Services Product
Table 104. Recipharm Revenue in Pharmaceutical CMO Services Business (2016-2021) & (US$ Million)
Table 105. Recipharm Recent Development
Table 106. Teva API Company Details
Table 107. Teva API Business Overview
Table 108. Teva API Pharmaceutical CMO Services Product
Table 109. Teva API Revenue in Pharmaceutical CMO Services Business (2016-2021) & (US$ Million)
Table 110. Teva API Recent Development
Table 111. Catalent Company Details
Table 112. Catalent Business Overview
Table 113. Catalent Pharmaceutical CMO Services Product
Table 114. Catalent Revenue in Pharmaceutical CMO Services Business (2016-2021) & (US$ Million)
Table 115. Catalent Recent Development
Table 116. Esteve Quimica Company Details
Table 117. Esteve Quimica Business Overview
Table 118. Esteve Quimica Pharmaceutical CMO Services Product
Table 119. Esteve Quimica Revenue in Pharmaceutical CMO Services Business (2016-2021) & (US$ Million)
Table 120. Esteve Quimica Recent Development
Table 121. Fareva Company Details
Table 122. Fareva Business Overview
Table 123. Fareva Pharmaceutical CMO Services Product
Table 124. Fareva Revenue in Pharmaceutical CMO Services Business (2016-2021) & (US$ Million)
Table 125. Fareva Recent Development
Table 126. Patheon Company Details
Table 127. Patheon Business Overview
Table 128. Patheon Pharmaceutical CMO Services Product
Table 129. Patheon Revenue in Pharmaceutical CMO Services Business (2016-2021) & (US$ Million)
Table 130. Patheon Recent Development
Table 131. Piramal Company Details
Table 132. Piramal Business Overview
Table 133. Piramal Pharmaceutical CMO Services Product
Table 134. Piramal Revenue in Pharmaceutical CMO Services Business (2016-2021) & (US$ Million)
Table 135. Piramal Recent Development
Table 136. Hisun Pharmaceuticals Company Details
Table 137. Hisun Pharmaceuticals Business Overview
Table 138. Hisun Pharmaceuticals Pharmaceutical CMO Services Product
Table 139. Hisun Pharmaceuticals Revenue in Pharmaceutical CMO Services Business (2016-2021) & (US$ Million)
Table 140. Hisun Pharmaceuticals Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmaceutical CMO Services Market Share by Type: 2020 VS 2027
Figure 2. Active Pharmaceutical Ingredients (APIs) Features
Figure 3. Finished Dose Formulations (FDFs) Features
Figure 4. Packaging Features
Figure 5. Global Pharmaceutical CMO Services Market Share by Application: 2020 VS 2027
Figure 6. Pharmaceutical Industry Case Studies
Figure 7. Biotechnology Industry Case Studies
Figure 8. Pharmaceutical CMO Services Report Years Considered
Figure 9. Global Pharmaceutical CMO Services Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Pharmaceutical CMO Services Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Pharmaceutical CMO Services Market Share by Regions: 2020 VS 2027
Figure 12. Global Pharmaceutical CMO Services Market Share by Regions (2022-2027)
Figure 13. Global Pharmaceutical CMO Services Market Share by Players in 2020
Figure 14. Global Top Pharmaceutical CMO Services Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutical CMO Services as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Pharmaceutical CMO Services Revenue in 2020
Figure 16. Global Pharmaceutical CMO Services Revenue Market Share by Type (2016-2021)
Figure 17. Global Pharmaceutical CMO Services Revenue Market Share by Type (2022-2027)
Figure 18. North America Pharmaceutical CMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Pharmaceutical CMO Services Market Share by Type (2016-2027)
Figure 20. North America Pharmaceutical CMO Services Market Share by Application (2016-2027)
Figure 21. North America Pharmaceutical CMO Services Market Share by Country (2016-2027)
Figure 22. United States Pharmaceutical CMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Pharmaceutical CMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Pharmaceutical CMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Pharmaceutical CMO Services Market Share by Type (2016-2027)
Figure 26. Europe Pharmaceutical CMO Services Market Share by Application (2016-2027)
Figure 27. Europe Pharmaceutical CMO Services Market Share by Country (2016-2027)
Figure 28. Germany Pharmaceutical CMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Pharmaceutical CMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Pharmaceutical CMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Pharmaceutical CMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Pharmaceutical CMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Pharmaceutical CMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Pharmaceutical CMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Pharmaceutical CMO Services Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Pharmaceutical CMO Services Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Pharmaceutical CMO Services Market Share by Region (2016-2027)
Figure 38. China Pharmaceutical CMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Pharmaceutical CMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Pharmaceutical CMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Pharmaceutical CMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Pharmaceutical CMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Pharmaceutical CMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Pharmaceutical CMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Pharmaceutical CMO Services Market Share by Type (2016-2027)
Figure 46. Latin America Pharmaceutical CMO Services Market Share by Application (2016-2027)
Figure 47. Latin America Pharmaceutical CMO Services Market Share by Country (2016-2027)
Figure 48. Mexico Pharmaceutical CMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Pharmaceutical CMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Pharmaceutical CMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Pharmaceutical CMO Services Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Pharmaceutical CMO Services Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Pharmaceutical CMO Services Market Share by Country (2016-2027)
Figure 54. Turkey Pharmaceutical CMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Pharmaceutical CMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Pharmaceutical CMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Lonza Revenue Growth Rate in Pharmaceutical CMO Services Business (2016-2021)
Figure 58. Boehringer Ingelheim Revenue Growth Rate in Pharmaceutical CMO Services Business (2016-2021)
Figure 59. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Pharmaceutical CMO Services Business (2016-2021)
Figure 60. AGC Chemicals Revenue Growth Rate in Pharmaceutical CMO Services Business (2016-2021)
Figure 61. AbbVie Revenue Growth Rate in Pharmaceutical CMO Services Business (2016-2021)
Figure 62. Pfizer Revenue Growth Rate in Pharmaceutical CMO Services Business (2016-2021)
Figure 63. Evonik Health Care Revenue Growth Rate in Pharmaceutical CMO Services Business (2016-2021)
Figure 64. Delpharm Revenue Growth Rate in Pharmaceutical CMO Services Business (2016-2021)
Figure 65. Recipharm Revenue Growth Rate in Pharmaceutical CMO Services Business (2016-2021)
Figure 66. Teva API Revenue Growth Rate in Pharmaceutical CMO Services Business (2016-2021)
Figure 67. Catalent Revenue Growth Rate in Pharmaceutical CMO Services Business (2016-2021)
Figure 68. Esteve Quimica Revenue Growth Rate in Pharmaceutical CMO Services Business (2016-2021)
Figure 69. Fareva Revenue Growth Rate in Pharmaceutical CMO Services Business (2016-2021)
Figure 70. Patheon Revenue Growth Rate in Pharmaceutical CMO Services Business (2016-2021)
Figure 71. Piramal Revenue Growth Rate in Pharmaceutical CMO Services Business (2016-2021)
Figure 72. Hisun Pharmaceuticals Revenue Growth Rate in Pharmaceutical CMO Services Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
世界のヘパリン有効成分市場 2021：企業別、地域別、種類・用途別 The Heparin Active Pharmaceutical Ingredients market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…- 世界の医薬品ブリスター包装市場規模・現状・予測（2021年-2027年） Blister pack is a term for several types of pre-formed plastic packaging used for small consumer goods, foods, and for pharmaceuticals. The primary component of a blister pack is a cavity or pocket made from a formable web, usually a thermoformed plastic. This usually has a backing of paperboard or …
- 世界の偽造防止医薬品包装市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti-counterfeit Pharmaceutical Packaging Market The global Anti-counterfeit Pharmaceutical Packaging market size is projected to reach US$ 148.5 million by 2026, from US$ 95 million in 2019, at a CAGR of 6.5% during 2021-2026. With industry-standard accuracy in …
- 世界の医薬品契約パッケージング市場規模・現状・予測（2021年-2027年） Pharmaceutical Contract Packaging is the overall process of assembling a Pharmaceutical product into its final finished packaging. USA has the largest North America export quantity and manufacturers in Pharmaceutical Contract Packaging market, while the Canada is the second sales volume market for i…
- 世界の医薬品用無菌包装市場規模・現状・予測（2021年-2027年） Aseptic Packaging for the Pharmaceutical Industry is the process by which a sterile (aseptic) pharmaceutical is packaged in a sterile container in a way that maintains sterility. Sterile pharmaceuticals are usually packaged in plastic or glass. Together these materials form a tight seal against micr…